ParhainHinta.fi
Rare Disease Drug Development

Springer

Rare Disease Drug Development

Alin havaittu hinta

49,49 €
1 kauppa

Hinnat kaupoissa

1 tarjous
Springer Nature Link Shop
Havaittu
49,49 €
Siirry kauppaan

Hinnat ovat viimeksi havaittuja. Tarkista ajantasainen hinta, saatavuus ja toimituskulut kaupasta.

Hintahistoria

1 hintahavainto

Kaavio näyttää kunkin havaintopäivän alimman tallennetun tuotehinnan. Havaintojen välistä hintaa ei ole vahvistettu.

Hinta nyt 49,49 €. Alin havaittu 49,49 €, korkein 49,49 €.

Alin havaittu
49,49 €
Korkein havaittu
49,49 €
Viimeisin historian havainto
Hintahistoria: 1 havaintopäivä49,49 €8.11.2026: 49,49 €8.11.2026
Näytä hintahavainto
Hinta havaittu (Suomen aika)Hinta
49,49 €

Tuotetiedot

This book provides a broad overview of rare disease drug development. It offers unique insights from various perspectives, including third-party capital providers, caregivers, patient advocacy groups, drug development professionals, marketing and commercial experts, and patients. A unique reference, the book begins with narratives on the many challenges faced by rare disease patient and their caregivers. Subsequent chapters underscore the critical, multidimensional role of patient advocacy groups and the novel approaches to related clinical trials, investment decisions, and the optimization of rare disease registries. The book addresses various rare disease drug development processes by disciplines such as oncology, hematology, pediatrics, and gene therapy. Chapters then address the operational aspects of drug development, including approval processes, development accelerations, and market access strategies. The book concludes with reflections on the authors' case forreal-world data and evidence generation in orphan medicinal drug development. Rare Disease Drug Development is an expertly written text optimized for biopharmaceutical R&D experts, commercial experts, third-party capital providers, patient advocacy groups, patients, and caregivers.

Brändi
Springer
EAN / GTIN
9783030786045